This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Liver/bile ducts (ICD-9) (controls excluding all cancers)
CD2_BENIGN_LIVER_BILE_9_EXALLC
No definition available.
Endpoint definition
↥individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
24
Control definitions
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Benign neoplasm: Liver/bile ducts (ICD-9) (controls excluding all cancers) based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Liver/bile ducts (ICD-9)
- Benign neoplasm: Small intestine (controls excluding all cancers)
- Benign neoplasm: Small intestine
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 24 | 17 | 7 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.00 |
Mean age at first event (years) | 41.91 | 39.35 | 48.12 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_LIVER_BILE_9_EXALLC – Benign neoplasm: Liver/bile ducts (ICD-9) (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Liver/bile ducts (ICD-9) (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.